ConductScience.org, home

Gene · 50512

PODXL2: podocalyxin like 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. PODXL2: podocalyxin like 2. Genes, record 50512. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/50512

On this page

Gene

Symbol
PODXL2
HGNC
Name
podocalyxin like 2
HGNC
NCBI Gene ID
50512
NCBI Gene
HGNC ID
HGNC:17936
HGNC
Ensembl
ENSG00000114631
NCBI Gene
Aliases
EG, PODLX2, endoglycan
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9NZ53Podocalyxin-like protein 26050Ensembl, GeneID, HGNC

Source UniProt

Patents30

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-196973Q9NZ53Espacenet
EP 4641202 A22025-10-29378Q9NZ53Espacenet
EP 4641203 A22025-10-29208Q9NZ53Espacenet
JP 2025529142 A2025-09-043554Q9NZ53Espacenet
US 12371689 B22025-07-293554Q9NZ53Espacenet
JP 2025517967 A2025-06-12208Q9NZ53Espacenet
JP 2025517970 A2025-06-126973Q9NZ53Espacenet
KR 1020250017230 A2025-02-04208Q9NZ53Espacenet
KR 1020250017231 A2025-02-04378Q9NZ53Espacenet
US 11446398 B22022-09-2064403Q9NZ53Espacenet

1 to 10 of 30

See all 30 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants640

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitlePODXL2 papersNewest fiscal year
P30CA008748Cancer Center Support Grant42025
P30AG024827Pittsburgh Older Americans Independence Center32025
P30CA016672Cancer Center Support Grant32025
P30CA068485Cancer Center Support Grant32025
P30DK078392Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease32025
P30CA060553The Robert H. Lurie Comprehensive Cancer Center22025
R01GM129325ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling22025
U2CTR002818Data Management and Coordinating Center: Rare Diseases Clinical Research Network22025
D43TW007124Emory-Georgia TB Research Training Program12025
K08GM144788Mechanisms driving endothelial angiopoietin-2 expression and vascular dysfunction during pediatric sepsis12025

1 to 10 of 640Source NIH's project files

See all 640 nih grants

Papers2,142

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Cellulose nanocrystals formation leveraging synergy between lytic polysaccharide monooxygenase and endoglucanase.Bioprocess Biosyst Eng202642758155PubTator, text miningPubMed
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.Cancers (Basel)202642512369PubTator, text miningPubMed
Reactant-Sustained Dynamically Stable Interfacial Hydrogen-Bond Network for Highly Selective, Ampere-Level Ethylene Glycol Electrooxidation.Angew Chem Int Ed Engl202642466732PubTator, text miningPubMed
Structural Properties and Energy Band Alignment of Crystalline AlN Grown by Atomic Layer Deposition on Epitaxial Graphene.Nanomaterials (Basel)202642274666PubTator, text miningPubMed
Fabrication of graphene-based quantum Hall networks and influences of partial star-mesh recursion.Mater Res Express202642266375PubTator, text miningPubMed
Task-based fNIRS biomarkers of HD-tDCS treatment for negative symptoms in schizophrenia.Schizophr Res202642000633PubTator, text miningPubMed
The aging epigenome: integrative analyses reveal intersection with Alzheimer's disease.Geroscience202641975027PubTator, text miningPubMed
Alkali metal-induced modifications in the electronic and NLO properties of triselenasumanene complexes through DFT study.Sci Rep202641905986PubTator, text miningPubMed
The Effect of Intravenous Thrombolysis and Mechanical Thrombectomy on Change in the Concentrations of Interleukin-18 and Degradation Products of the Endothelial Glycocalyx in Patients with Acute Ischemic Stroke.
Life (Basel)202641900908PubTator, text miningPubMed
Enhanced Rashba Effect and Optical Absorption in 2D Janus XMoYZ2 (X = S/Se/Te; Y = Si/Ge; Z = N/P): A First-Principles Study.Nanomaterials (Basel)202641893233PubTator, text miningPubMed

1 to 10 of 2,142

See all 2,142 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/50512

GET https://conductscience.org/api/genes/v1/50512/patents?page=2